Inhibition of p27Kip1 gene transcription by mitogens

Cell Cycle

Volumn 8, Issue 1, 2009, Pages 115-124

  Bagui, Tapan K ^a   Cui, Dongming ^a   Roy, Sangita ^a   Mohapatra, Subhra ^a   Shor, Audrey C ^a   Ma, Le ^a   Pledger, W Jackson ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

c Myc; Histone deacetylase; p27Kip1; Platelet derived growth factor; Trichostatin A

Indexed keywords

CONCANAVALIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HISTONE DEACETYLASE; INTERLEUKIN 2; MITOGENIC AGENT; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; HYDROXAMIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE INHIBITOR; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROMOTER REGION; RNA STABILITY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGENS; NIH 3T3 CELLS; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-MYC; RNA STABILITY; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 60749098440     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.1.7527     Document Type: Article

References (89)

1. Olashaw N, Pledger WJ. Paradigms of growth control: relation to Cdk activation. Science STKE 2002; 2002:7.
2. Sherr CJ. D-type cyclins. Trends Biochem Sci 1995; 20:187-90.
3. 0 state) in fibroblasts. J Biol Chem 1996; 271:18337-41.
4. Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272:877-80.
5. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372:570-3.
6. Kip1) of cyclin-dependent kinase 4 activation. Cell 1994; 79:487-96.
7. Kip1. Mol Biol Cell 2000; 11:2117-30.
8. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66.
9. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78:67-74.
10. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-30.
11. Kip1. Genes Dev 1997; 11:1464-78.
12. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Embo J 1997; 16:5334-44.
13. Morisaki H, Fujimoto A, Ando A, Nagata Y, Ikeda K, Nakanishi M. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Biochem Biophys Res Commun 1997; 240:386-90.
14. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999; 13:1181-9.
15. 1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol Cell Biol 1999;19:1190-201.
16. Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2002; 277:28706-13.
17. Kip1. J Biol Chem 2001; 276:12084-90.
18. Kip1 is instigated by Jab1. Nature 1999; 398:160-5.
19. 1 and S phase. Nature 2001; 413:323-7.
20. 1 transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem 2001; 276:48937-43.
21. van Gorp AG, Pomeranz KM, Birkenkamp KU, Hui RC, Lam EW, Coffer PJ. Chronic protein kinase B (PKB/c-akt) activation leads to apoptosis induced by oxidative stress-mediated Foxo3a transcriptional upregulation. Cancer Res 2006; 66:10760-9.
22. Millard SS, Vidal A, Markus M, Koff A. A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA. Mol Cell Biol 2000; 20:5947-59.
23. kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996;16:4327-36.
24. kip1 gene expression. J Biol Chem 2001; 276:35636-43.
25. Kip1. J Biol Chem 2003; 278:29619-25.
26. Kip1 expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol 2000; 148:543-56.
27. Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation 2003; 108:616-22.
28. Kip1 in primary skeletal muscle satellite cells. J Cell Physiol 2003; 196:523-31.
29. 1 to S cell cycle transition. Embo J 1998; 17:6670-7.
30. Kip1. Nature 2000; 404:782-7.
31. KIP1. Mol Cell Biol 2000; 20:9138-48.
32. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999;398:630-4.
33. Rena G, Guo S, Cichy SC, Unterman TG, Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 1999; 274:17179-83.
34. Brownawell AM, Kops GJ, Macara IG, Burgering BM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 2001; 21:3534-46.
35. Kip1 and Bim in response to IL-2. J Immunol 2002; 168:5024-31.
36. Abid MR, Yano K, Guo S, Patel VI, Shrikhande G, Spokes KC, Ferran C, Aird WC. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Biol Chem 2005; 280:29864-73.
37. Kip1 gene promoter that lacks vitamin D response elements. J Biol Chem 1999; 274:32309-17.
38. Kip1 by tamoxifen. Biochem Pharmacol 2003; 66:371-7.
39. Kip1. Oncogene 2002; 21:3199-206.
40. Kip1 by the VDR/Sp1 complex. J Cell Biochem 2006; 98:1450-6.
41. Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999; 13:1742-53.
42. Kip1 is upregulated by hypoxia via an ARNT-dependent pathway. J Cell Biochem 2003; 90:548-60.
43. Kip1 Expression by E2F1. A negative feedback mechanism. J Biol Chem 2005; 280:12339-43.
44. Kip1 transactivation. J Cell Sci 2006; 119:1433-41.
45. Kip1 transcription, coordinating neural progenitor cell cycle exit and differentiation. Mol Cell Biol 2006; 26:8826-39.
46. Gizard F, Robillard R, Gross B, Barbier O, Revillion F, Peyrat JP, Torpier G, Hum DW, Staels B. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. Mol Cell Biol 2006; 26:7632-44.
47. Laub F, Lei L, Sumiyoshi H, Kajimura D, Dragomir C, Smaldone S, Puche AC, Petros TJ, Mason C, Parada LF, Ramirez F. Transcription factor KLF7 is important for neuronal morphogenesis in selected regions of the nervous system. Mol Cell Biol 2005; 25:5699-711.
48. kip1 expression during nephrogenesis, glomerular abnormalities and multiorgan hyperplasia. Dev Biol 2002; 245:157-71.
49. kip1 through Notch/HRT2 signaling in vascular smooth muscle cells. Thromb Haemost 2006; 96:361-70.
50. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 2001; 20:1688-702.
51. Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. Embo J 2002; 21:2672-81.
52. Waf1,Cip1,sdi1 expression in Hep3B cells. Exp Cell Res 1999; 253:618-28.
53. Murata K, Hattori M, Hirai N, Shinozuka Y, Hirata H, Kageyama R, Sakai T, Minato N. Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1. Mol Cell Biol 2005; 25:4262-71.
54. Garrett-Engele CM, Tasch MA, Hwang HC, Fero ML, Perlmutter RM, Clurman BE, Roberts JM. A mechanism misregulating p27 in tumors discovered in a functional genomic screen. PLoS Genet 2007; 3:2416-27.
55. Kip1. Oncogene 2000; 19:3290-8.
56. kip1) expression. Proc Natl Acad Sci USA 2005; 102:14028-33.
57. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 2005; 102:749-54.
58. Pledger WJ, Stiles CD, Antoniades HN, Scher CD. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci USA 1977; 74:4481-5.
59. kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J Biol Chem 1996; 271:11253-60.
60. Kip1 regulates T cell proliferation. J Biol Chem 2001; 276:21976-83.
61. Herzberg VL, Smith KA. T cell growth without serum. J Immunol 1987; 139:998-1004.
62. Kip1. Gene 1996; 180:113-20.
63. Zhang Y, Lin SC. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. Biochim Biophys Acta 1997; 1353:307-17.
64. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 1998; 335:1-13.
65. 1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem 2000; 275:35942-52.
66. L'Allemain G, Pouyssegur J, Weber MJ. p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: use of pertussis toxin as a discrimination factor. Cell Regul 1991; 2:675-84.
67. Mirza AM, Gysin S, Malek N, Nakayama K, Roberts JM, McMahon M. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol 2004;24:10868-81.
68. Kelly K, Cochran BH, Stiles CD, Leder P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 1983; 35:603-10.
69. Morgan CJ, Pledger WJ. Cell cycle-dependent growth factor regulation of gene expression. J Cell Physiol 1989; 141:535-42.
70. Olson JE, Winston JT, Whitlock JA, Pledger WJ. Cell cycle-dependent gene expression in V point-arrested BALB/c-3T3 cells. J Cell Physiol 1993; 154:333-42.
71. Kip1 levels. J Immunol 2004; 172:5522-7.
72. Wharton W, Savell J, Cress WD, Seto E, Pledger WJ. Inhibition of mitogenesis in Balb/c-3T3 cells by trichostatin A: Multiple alterations in the induction and activation of cyclincyclin-dependent kinase complexes. J Biol Chem 2000; 275:33981-7.
73. Cress WD, Seto E. Histone deacetylases, transcriptional control and cancer. J Cell Physiol 2000; 184:1-16.
74. 1/S transition through regulation of p27 expression. J Biol Chem 2001; 276:7919-26.
75. Sakakibara K, Kubota K, Worku B, Ryer EJ, Miller JP, Koff A, Kent KC, Liu B. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem 2005; 280:25470-7.
76. Leung-Pineda V, Pan Y, Chen H, Kilberg MS. Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization. Biochem J 2004; 379:79-88.
77. Kip1 gene. FEBS Lett 1999;455:281-5.
78. Claassen GF, Hann SR. Myc-mediated transformation: the repression connection. Oncogene 1999; 18:2925-33.
79. Kip1 cyclin-dependent kinase inhibitor. J Cell Biochem 2008; 104:2091-106.
80. Van Lint C, Emiliani S, Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 1996; 5:245-53.
81. Buckley AR, Leff MA, Buckley DJ, Magnuson NS, de Jong G, Gout PW. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells. Cell Growth Differ 1996; 7:1713-21.
82. WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Biochem Biophys Res Commun 2004; 324:860-7.
83. Lee SC, Bottaro A, Insel RA. Activation of terminal B cell differentiation by inhibition of histone deacetylation. Mol Immunol 2003; 39:923-32.
84. Kim YB, Yoshida M, Horinouchi S. Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase. Ann NY Acad Sci 1999; 886:200-3.
85. WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 2000; 97:10014-9.
86. Finzer P, Kuntzen C, Soto U, zur Hausen H, Rosl F. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene 2001; 20:4768-76.
87. 1 arrest in fibroblasts. J Cell Physiol 2005;02:87-99.
88. WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 1998; 95:6791-6.
89. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H, Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997; 272:22199-206.